

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 6.85886662 |
| 2 | regulation of chronic inflammatory response (GO:0002676) | 6.78178490 |
| 3 | positive regulation of heat generation (GO:0031652) | 6.14598191 |
| 4 | regulation of fever generation (GO:0031620) | 6.11506061 |
| 5 | regulation of vitamin metabolic process (GO:0030656) | 5.45582192 |
| 6 | regulation of mononuclear cell migration (GO:0071675) | 5.34391817 |
| 7 | positive regulation of chemokine biosynthetic process (GO:0045080) | 5.30261513 |
| 8 | regulation of cytokine secretion involved in immune response (GO:0002739) | 5.29512888 |
| 9 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.86379360 |
| 10 | regulation of chemokine biosynthetic process (GO:0045073) | 4.84495483 |
| 11 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.83974490 |
| 12 | regulation of heat generation (GO:0031650) | 4.75856972 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 4.63217360 |
| 14 | regulation of podosome assembly (GO:0071801) | 4.63055234 |
| 15 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.55503892 |
| 16 | monocyte chemotaxis (GO:0002548) | 4.51043886 |
| 17 | eosinophil chemotaxis (GO:0048245) | 4.49164247 |
| 18 | negative regulation of cytokine production involved in immune response (GO:0002719) | 4.31531625 |
| 19 | cellular response to type I interferon (GO:0071357) | 4.02315116 |
| 20 | type I interferon signaling pathway (GO:0060337) | 4.02315116 |
| 21 | regulation of interferon-alpha production (GO:0032647) | 4.02200616 |
| 22 | negative regulation of viral genome replication (GO:0045071) | 3.99654476 |
| 23 | eosinophil migration (GO:0072677) | 3.99055322 |
| 24 | response to type I interferon (GO:0034340) | 3.95599678 |
| 25 | regulation of immunoglobulin secretion (GO:0051023) | 3.95041119 |
| 26 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.91342301 |
| 27 | cellular response to nicotine (GO:0071316) | 3.89873199 |
| 28 | response to peptidoglycan (GO:0032494) | 3.89649229 |
| 29 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.88395058 |
| 30 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.86005100 |
| 31 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.84872540 |
| 32 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.83766830 |
| 33 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.81594170 |
| 34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.78115619 |
| 35 | activation of MAPKKK activity (GO:0000185) | 3.73596786 |
| 36 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.72617255 |
| 37 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.63961900 |
| 38 | positive regulation of acute inflammatory response (GO:0002675) | 3.63172559 |
| 39 | negative regulation of amino acid transport (GO:0051956) | 3.62500525 |
| 40 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.62468342 |
| 41 | myeloid dendritic cell differentiation (GO:0043011) | 3.55192686 |
| 42 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 3.53901867 |
| 43 | T cell migration (GO:0072678) | 3.53432371 |
| 44 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.46881336 |
| 45 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.44899790 |
| 46 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.37657479 |
| 47 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.35756702 |
| 48 | response to protozoan (GO:0001562) | 3.34323889 |
| 49 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.34158226 |
| 50 | regulation of growth of symbiont in host (GO:0044126) | 3.34158226 |
| 51 | negative regulation of growth of symbiont in host (GO:0044130) | 3.34158226 |
| 52 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.34158226 |
| 53 | granulocyte activation (GO:0036230) | 3.33986835 |
| 54 | lymphocyte chemotaxis (GO:0048247) | 3.33632920 |
| 55 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.28990415 |
| 56 | cellular response to lipopolysaccharide (GO:0071222) | 3.26771398 |
| 57 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.26400720 |
| 58 | macrophage chemotaxis (GO:0048246) | 3.21541979 |
| 59 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.18722633 |
| 60 | defense response to protozoan (GO:0042832) | 3.18472568 |
| 61 | immunoglobulin mediated immune response (GO:0016064) | 3.16198441 |
| 62 | regulation of interleukin-12 production (GO:0032655) | 3.15688733 |
| 63 | positive regulation of lymphocyte migration (GO:2000403) | 3.15266229 |
| 64 | positive regulation of interferon-alpha production (GO:0032727) | 3.13457935 |
| 65 | cellular response to molecule of bacterial origin (GO:0071219) | 3.13268643 |
| 66 | regulation of NF-kappaB import into nucleus (GO:0042345) | 3.12798138 |
| 67 | negative regulation of lipid storage (GO:0010888) | 3.09490060 |
| 68 | myeloid dendritic cell activation (GO:0001773) | 3.09240776 |
| 69 | macrophage activation involved in immune response (GO:0002281) | 3.08857284 |
| 70 | positive regulation of defense response to virus by host (GO:0002230) | 3.08822868 |
| 71 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.08251667 |
| 72 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.06561593 |
| 73 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 3.06245148 |
| 74 | positive regulation of humoral immune response (GO:0002922) | 3.05169016 |
| 75 | positive regulation of type 2 immune response (GO:0002830) | 3.03633720 |
| 76 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.02879138 |
| 77 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.01698259 |
| 78 | regulation of T-helper cell differentiation (GO:0045622) | 3.00977285 |
| 79 | T-helper 1 type immune response (GO:0042088) | 2.99764865 |
| 80 | positive regulation of interleukin-6 production (GO:0032755) | 2.98648264 |
| 81 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.98565818 |
| 82 | NIK/NF-kappaB signaling (GO:0038061) | 2.95167957 |
| 83 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.94043327 |
| 84 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.93581602 |
| 85 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.91412519 |
| 86 | positive regulation of hair follicle development (GO:0051798) | 2.89510414 |
| 87 | positive regulation of hair cycle (GO:0042635) | 2.89510414 |
| 88 | regulation of lymphocyte migration (GO:2000401) | 2.88975933 |
| 89 | negative regulation of viral process (GO:0048525) | 2.87944812 |
| 90 | germinal center formation (GO:0002467) | 2.87539636 |
| 91 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.86019758 |
| 92 | positive regulation of B cell mediated immunity (GO:0002714) | 2.82502823 |
| 93 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.82502823 |
| 94 | cellular response to interferon-gamma (GO:0071346) | 2.82237170 |
| 95 | positive regulation of interleukin-12 production (GO:0032735) | 2.82179513 |
| 96 | negative regulation by host of viral transcription (GO:0043922) | 2.81441609 |
| 97 | regulation of type 2 immune response (GO:0002828) | 2.81193189 |
| 98 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.80926415 |
| 99 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.80856050 |
| 100 | regulation of viral genome replication (GO:0045069) | 2.80504688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.85235894 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.02375326 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.47883053 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.84988726 |
| 5 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 4.34650681 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.74832785 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.70317132 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.53416384 |
| 9 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.38041239 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.34350466 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.20724609 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.16148296 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.88985917 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.85590219 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.79810855 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.59998212 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.55293962 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.37569568 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.33179105 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20966295 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.11767399 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.85694581 |
| 23 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.83542392 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.79035638 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75943282 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.75839893 |
| 27 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.69288165 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 1.66922984 |
| 29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66579548 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.57191354 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.52249067 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.48110390 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.47738020 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46850589 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.44921376 |
| 36 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.43915304 |
| 37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41200135 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40410701 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39784376 |
| 40 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39313431 |
| 41 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36210054 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.35679039 |
| 43 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34834793 |
| 44 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34507418 |
| 45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32212765 |
| 46 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.29859168 |
| 47 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24091064 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23033633 |
| 49 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.22979078 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22564850 |
| 51 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20432689 |
| 52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.19330661 |
| 53 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18840352 |
| 54 | MYB_26560356_Chip-Seq_TH1_Human | 1.18661570 |
| 55 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16622159 |
| 56 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13865869 |
| 57 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12461406 |
| 58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.11755962 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10212661 |
| 60 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08989775 |
| 61 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.08705208 |
| 62 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.08705208 |
| 63 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.08705208 |
| 64 | MAF_26560356_Chip-Seq_TH2_Human | 1.08660083 |
| 65 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06495539 |
| 66 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06233411 |
| 67 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04918617 |
| 68 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.01970921 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01489899 |
| 70 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00671742 |
| 71 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99999905 |
| 72 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.99407976 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99198028 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97030618 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96467797 |
| 76 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.96117814 |
| 77 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.95980061 |
| 78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95144528 |
| 79 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94798205 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92893867 |
| 81 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.91600292 |
| 82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89069824 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88043499 |
| 84 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86385741 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84689850 |
| 86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.84475883 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.83710017 |
| 88 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81547514 |
| 89 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79722151 |
| 90 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.79681949 |
| 91 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78358486 |
| 92 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.75925655 |
| 93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.74403892 |
| 94 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72913643 |
| 95 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.69645257 |
| 96 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.68911958 |
| 97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.68897969 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68795530 |
| 99 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.68041677 |
| 100 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.67699964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 6.07472510 |
| 2 | MP0006082_CNS_inflammation | 4.46330169 |
| 3 | MP0009785_altered_susceptibility_to | 3.91748068 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.69323341 |
| 5 | MP0005671_abnormal_response_to | 3.63852543 |
| 6 | MP0003436_decreased_susceptibility_to | 3.54205877 |
| 7 | MP0003724_increased_susceptibility_to | 3.01312927 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.96334667 |
| 9 | MP0004510_myositis | 2.92017940 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.88750338 |
| 11 | MP0009764_decreased_sensitivity_to | 2.73896345 |
| 12 | MP0001790_abnormal_immune_system | 2.61278838 |
| 13 | MP0005387_immune_system_phenotype | 2.61278838 |
| 14 | MP0005025_abnormal_response_to | 2.52922848 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.52455277 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 2.39322397 |
| 17 | MP0002419_abnormal_innate_immunity | 2.38446652 |
| 18 | MP0008004_abnormal_stomach_pH | 2.37077879 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.29852952 |
| 20 | MP0002723_abnormal_immune_serum | 2.23900480 |
| 21 | MP0003075_altered_response_to | 2.22263181 |
| 22 | MP0001800_abnormal_humoral_immune | 2.21193347 |
| 23 | MP0004947_skin_inflammation | 2.16200436 |
| 24 | MP0002452_abnormal_antigen_presenting | 2.14167045 |
| 25 | MP0009840_abnormal_foam_cell | 2.08166224 |
| 26 | MP0010155_abnormal_intestine_physiology | 2.06184344 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 2.04108178 |
| 28 | MP0001533_abnormal_skeleton_physiology | 2.01275470 |
| 29 | MP0002332_abnormal_exercise_endurance | 1.99247305 |
| 30 | MP0000343_altered_response_to | 1.98601358 |
| 31 | MP0003448_altered_tumor_morphology | 1.87722901 |
| 32 | MP0001853_heart_inflammation | 1.87304189 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.86787590 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.84296271 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.80967450 |
| 36 | MP0001819_abnormal_immune_cell | 1.80428473 |
| 37 | MP0005451_abnormal_body_composition | 1.79029169 |
| 38 | MP0003195_calcinosis | 1.72740715 |
| 39 | MP0008469_abnormal_protein_level | 1.66861512 |
| 40 | MP0002405_respiratory_system_inflammati | 1.58324227 |
| 41 | MP0003453_abnormal_keratinocyte_physiol | 1.53193016 |
| 42 | MP0006054_spinal_hemorrhage | 1.52799894 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.43670087 |
| 44 | MP0005166_decreased_susceptibility_to | 1.42745198 |
| 45 | MP0005310_abnormal_salivary_gland | 1.40145386 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.39961495 |
| 47 | MP0003690_abnormal_glial_cell | 1.38600204 |
| 48 | MP0009278_abnormal_bone_marrow | 1.38438498 |
| 49 | MP0000604_amyloidosis | 1.37650978 |
| 50 | MP0000716_abnormal_immune_system | 1.32791343 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.31568696 |
| 52 | MP0000685_abnormal_immune_system | 1.30420430 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.28536322 |
| 54 | MP0002254_reproductive_system_inflammat | 1.28346616 |
| 55 | MP0000858_altered_metastatic_potential | 1.18801696 |
| 56 | MP0005464_abnormal_platelet_physiology | 1.14562123 |
| 57 | MP0002398_abnormal_bone_marrow | 1.13989065 |
| 58 | MP0009763_increased_sensitivity_to | 1.13603427 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.12844822 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.12844822 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.11067372 |
| 62 | MP0003646_muscle_fatigue | 1.09352575 |
| 63 | MP0009765_abnormal_xenobiotic_induced | 1.08850286 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.03158317 |
| 65 | MP0005165_increased_susceptibility_to | 1.00286652 |
| 66 | MP0001542_abnormal_bone_strength | 0.98911588 |
| 67 | MP0002429_abnormal_blood_cell | 0.98768851 |
| 68 | MP0005164_abnormal_response_to | 0.98022411 |
| 69 | MP0000920_abnormal_myelination | 0.94887478 |
| 70 | MP0000689_abnormal_spleen_morphology | 0.93325445 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 0.90854641 |
| 72 | MP0005647_abnormal_sex_gland | 0.89954826 |
| 73 | MP0002722_abnormal_immune_system | 0.89700040 |
| 74 | MP0005390_skeleton_phenotype | 0.89237541 |
| 75 | MP0010307_abnormal_tumor_latency | 0.81020466 |
| 76 | MP0001663_abnormal_digestive_system | 0.77211200 |
| 77 | MP0002933_joint_inflammation | 0.74239593 |
| 78 | MP0008874_decreased_physiological_sensi | 0.73410178 |
| 79 | MP0004808_abnormal_hematopoietic_stem | 0.68766275 |
| 80 | MP0005666_abnormal_adipose_tissue | 0.68418156 |
| 81 | MP0001727_abnormal_embryo_implantation | 0.68152993 |
| 82 | MP0001873_stomach_inflammation | 0.67715395 |
| 83 | MP0003091_abnormal_cell_migration | 0.66518108 |
| 84 | MP0005023_abnormal_wound_healing | 0.65956106 |
| 85 | MP0005535_abnormal_body_temperature | 0.65817617 |
| 86 | MP0002877_abnormal_melanocyte_morpholog | 0.63815050 |
| 87 | MP0005266_abnormal_metabolism | 0.62105971 |
| 88 | MP0010352_gastrointestinal_tract_polyps | 0.59854368 |
| 89 | MP0003045_fibrosis | 0.59648595 |
| 90 | MP0000249_abnormal_blood_vessel | 0.58294410 |
| 91 | MP0003795_abnormal_bone_structure | 0.55800933 |
| 92 | MP0003866_abnormal_defecation | 0.52137162 |
| 93 | MP0002693_abnormal_pancreas_physiology | 0.51904194 |
| 94 | MP0008873_increased_physiological_sensi | 0.50729257 |
| 95 | MP0003191_abnormal_cellular_cholesterol | 0.49409760 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.47914012 |
| 97 | MP0000609_abnormal_liver_physiology | 0.47836841 |
| 98 | MP0005319_abnormal_enzyme/_coenzyme | 0.47692467 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.47668276 |
| 100 | MP0001764_abnormal_homeostasis | 0.47640874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.70244765 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.70244765 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 6.70244765 |
| 4 | Optic neuritis (HP:0100653) | 5.90437369 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 5.90437369 |
| 6 | Orchitis (HP:0100796) | 5.53546503 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.98479243 |
| 8 | Myositis (HP:0100614) | 4.79234198 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 4.70400770 |
| 10 | Stomatitis (HP:0010280) | 4.41101816 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.32200726 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.16667895 |
| 13 | Autoimmune thrombocytopenia (HP:0001973) | 4.07503309 |
| 14 | Keratoconjunctivitis sicca (HP:0001097) | 4.06270578 |
| 15 | Dysostosis multiplex (HP:0000943) | 4.03050291 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.85255006 |
| 17 | Loss of speech (HP:0002371) | 3.84052421 |
| 18 | Disinhibition (HP:0000734) | 3.80013679 |
| 19 | Nausea (HP:0002018) | 3.74895393 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.73150576 |
| 21 | Keratoconjunctivitis (HP:0001096) | 3.71769671 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 3.70153004 |
| 23 | T lymphocytopenia (HP:0005403) | 3.66428212 |
| 24 | Mutism (HP:0002300) | 3.59363719 |
| 25 | Gangrene (HP:0100758) | 3.55915980 |
| 26 | Nuclear cataract (HP:0100018) | 3.54466776 |
| 27 | Autoimmune hemolytic anemia (HP:0001890) | 3.45353614 |
| 28 | Abnormality of T cell number (HP:0011839) | 3.44339755 |
| 29 | Neurofibrillary tangles (HP:0002185) | 3.36847002 |
| 30 | Pulmonary infiltrates (HP:0002113) | 3.28313386 |
| 31 | Vasculitis (HP:0002633) | 3.19846046 |
| 32 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.17127712 |
| 33 | Hematochezia (HP:0002573) | 3.07091411 |
| 34 | Increased IgM level (HP:0003496) | 3.06611360 |
| 35 | Hemoptysis (HP:0002105) | 3.03691888 |
| 36 | Eczematoid dermatitis (HP:0000976) | 3.03200879 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.99608617 |
| 38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.99608617 |
| 39 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.99608617 |
| 40 | Parakeratosis (HP:0001036) | 2.95846936 |
| 41 | Increased serum ferritin (HP:0003281) | 2.89584605 |
| 42 | Recurrent viral infections (HP:0004429) | 2.75423837 |
| 43 | Mucopolysacchariduria (HP:0008155) | 2.73029019 |
| 44 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.73029019 |
| 45 | Polyneuropathy (HP:0001271) | 2.71225024 |
| 46 | Apathy (HP:0000741) | 2.62961629 |
| 47 | Abnormality of the pleura (HP:0002103) | 2.61682574 |
| 48 | Joint swelling (HP:0001386) | 2.61002237 |
| 49 | Arterial thrombosis (HP:0004420) | 2.59750641 |
| 50 | Zonular cataract (HP:0010920) | 2.58575213 |
| 51 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58436485 |
| 52 | Encephalitis (HP:0002383) | 2.58283326 |
| 53 | Glomerulonephritis (HP:0000099) | 2.56669802 |
| 54 | Obstructive lung disease (HP:0006536) | 2.53230101 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.53230101 |
| 56 | Meningitis (HP:0001287) | 2.51732683 |
| 57 | Diminished motivation (HP:0000745) | 2.48826529 |
| 58 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.48712865 |
| 59 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.48584029 |
| 60 | Anorexia (HP:0002039) | 2.47629468 |
| 61 | Abnormality of the pericardium (HP:0001697) | 2.42804067 |
| 62 | Progressive neurologic deterioration (HP:0002344) | 2.34575357 |
| 63 | Interstitial pulmonary disease (HP:0006530) | 2.32307375 |
| 64 | Recurrent skin infections (HP:0001581) | 2.30509682 |
| 65 | Hepatosplenomegaly (HP:0001433) | 2.30496076 |
| 66 | Cerebral inclusion bodies (HP:0100314) | 2.28973774 |
| 67 | Basal ganglia calcification (HP:0002135) | 2.26326212 |
| 68 | Recurrent fungal infections (HP:0002841) | 2.23786033 |
| 69 | Vertigo (HP:0002321) | 2.22619042 |
| 70 | Agnosia (HP:0010524) | 2.21280604 |
| 71 | Leukocytosis (HP:0001974) | 2.19551470 |
| 72 | Abnormality of iron homeostasis (HP:0011031) | 2.18728668 |
| 73 | Pulmonary embolism (HP:0002204) | 2.14861061 |
| 74 | Abnormality of B cell number (HP:0010975) | 2.14730339 |
| 75 | Axonal loss (HP:0003447) | 2.13344560 |
| 76 | Hypergammaglobulinemia (HP:0010702) | 2.12529043 |
| 77 | Neuronal loss in central nervous system (HP:0002529) | 2.12322888 |
| 78 | IgA deficiency (HP:0002720) | 2.11954310 |
| 79 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.11776723 |
| 80 | Glomerulopathy (HP:0100820) | 2.11751987 |
| 81 | Memory impairment (HP:0002354) | 2.11492215 |
| 82 | Gastrointestinal infarctions (HP:0005244) | 2.11224560 |
| 83 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.10000945 |
| 84 | Acne (HP:0001061) | 2.09783291 |
| 85 | Metaphyseal irregularity (HP:0003025) | 2.04790200 |
| 86 | Thoracolumbar scoliosis (HP:0002944) | 2.03891919 |
| 87 | Amyloidosis (HP:0011034) | 2.03440226 |
| 88 | B lymphocytopenia (HP:0010976) | 2.02565528 |
| 89 | Purpura (HP:0000979) | 2.00886523 |
| 90 | Abnormality of T cells (HP:0002843) | 2.00480657 |
| 91 | Inappropriate behavior (HP:0000719) | 1.99454962 |
| 92 | Prolonged neonatal jaundice (HP:0006579) | 1.98508963 |
| 93 | Complement deficiency (HP:0004431) | 1.97729865 |
| 94 | Personality changes (HP:0000751) | 1.96718029 |
| 95 | Keratitis (HP:0000491) | 1.96366222 |
| 96 | Myocardial infarction (HP:0001658) | 1.94979893 |
| 97 | Arthralgia (HP:0002829) | 1.93723242 |
| 98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.92134741 |
| 99 | Recurrent bronchitis (HP:0002837) | 1.91436102 |
| 100 | Abnormality of the endocardium (HP:0004306) | 1.90079109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 6.57708735 |
| 2 | GRK7 | 4.35717527 |
| 3 | TXK | 3.93501912 |
| 4 | TAOK2 | 3.21171293 |
| 5 | MAP3K14 | 3.04668987 |
| 6 | NME2 | 2.99892125 |
| 7 | DDR2 | 2.83759151 |
| 8 | TBK1 | 2.82384906 |
| 9 | MATK | 2.50719630 |
| 10 | RIPK1 | 2.48410633 |
| 11 | IRAK4 | 2.46467105 |
| 12 | MAP4K1 | 2.40757310 |
| 13 | IKBKE | 2.30235137 |
| 14 | IKBKB | 2.21483866 |
| 15 | ADRBK2 | 2.20744305 |
| 16 | BMPR2 | 2.17591415 |
| 17 | BLK | 2.09277030 |
| 18 | PIM2 | 2.01184310 |
| 19 | MOS | 1.94659686 |
| 20 | TAOK1 | 1.93365420 |
| 21 | MAP3K11 | 1.87418754 |
| 22 | RIPK4 | 1.87255929 |
| 23 | CSK | 1.72534990 |
| 24 | MAP3K3 | 1.68979317 |
| 25 | PRPF4B | 1.68836400 |
| 26 | FGR | 1.61421464 |
| 27 | TYK2 | 1.59356772 |
| 28 | JAK3 | 1.51054282 |
| 29 | TGFBR2 | 1.50053667 |
| 30 | IRAK2 | 1.43553266 |
| 31 | CHUK | 1.38767242 |
| 32 | TYRO3 | 1.31036931 |
| 33 | IRAK1 | 1.30304527 |
| 34 | CDC42BPA | 1.21260984 |
| 35 | ACVR1B | 1.14087873 |
| 36 | ZAP70 | 1.11241652 |
| 37 | MAP3K5 | 1.10651964 |
| 38 | LYN | 1.06492562 |
| 39 | SYK | 1.03278947 |
| 40 | JAK1 | 1.01902028 |
| 41 | ABL2 | 0.96661494 |
| 42 | MAP2K3 | 0.95471393 |
| 43 | ITK | 0.86049079 |
| 44 | MAP3K1 | 0.85696718 |
| 45 | CLK1 | 0.85424800 |
| 46 | LCK | 0.83815585 |
| 47 | STK10 | 0.83216845 |
| 48 | JAK2 | 0.82484685 |
| 49 | LATS2 | 0.81069040 |
| 50 | MAP2K6 | 0.80080130 |
| 51 | KDR | 0.73600904 |
| 52 | PIM1 | 0.71264824 |
| 53 | TAOK3 | 0.65270867 |
| 54 | CSF1R | 0.63869803 |
| 55 | PKN1 | 0.61001714 |
| 56 | MARK3 | 0.60473466 |
| 57 | ERN1 | 0.59902613 |
| 58 | TESK2 | 0.58470565 |
| 59 | MAP3K13 | 0.53675071 |
| 60 | EIF2AK2 | 0.45595720 |
| 61 | FES | 0.45445407 |
| 62 | PDGFRA | 0.43377807 |
| 63 | DAPK2 | 0.42718965 |
| 64 | MAPK4 | 0.42264447 |
| 65 | EIF2AK3 | 0.42127249 |
| 66 | BTK | 0.41621991 |
| 67 | HCK | 0.41452280 |
| 68 | DYRK3 | 0.39083214 |
| 69 | INSR | 0.36430322 |
| 70 | DAPK3 | 0.33811325 |
| 71 | PRKCQ | 0.33638120 |
| 72 | CDK6 | 0.32765144 |
| 73 | BCKDK | 0.31971984 |
| 74 | HIPK2 | 0.31862369 |
| 75 | PDGFRB | 0.30297608 |
| 76 | FYN | 0.30013022 |
| 77 | ARAF | 0.29509502 |
| 78 | BMX | 0.28830914 |
| 79 | PDK1 | 0.25753022 |
| 80 | GSK3A | 0.23961277 |
| 81 | ABL1 | 0.23885217 |
| 82 | CAMKK2 | 0.23242649 |
| 83 | MELK | 0.22284689 |
| 84 | KIT | 0.22236000 |
| 85 | EGFR | 0.20612894 |
| 86 | STK16 | 0.20403275 |
| 87 | SIK3 | 0.17880138 |
| 88 | TRIM28 | 0.17516141 |
| 89 | MAPKAPK2 | 0.16004454 |
| 90 | PAK4 | 0.15704262 |
| 91 | ZAK | 0.14996302 |
| 92 | EPHA3 | 0.14837269 |
| 93 | CDK14 | 0.14551357 |
| 94 | TESK1 | 0.14347831 |
| 95 | CDK15 | 0.13744530 |
| 96 | PRKCD | 0.13344107 |
| 97 | IGF1R | 0.12280153 |
| 98 | PIK3CA | 0.11049754 |
| 99 | CDK18 | 0.10382679 |
| 100 | MAPK3 | 0.08656928 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.26480389 |
| 2 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.24314074 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.15117318 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.10152694 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.04134453 |
| 6 | Malaria_Homo sapiens_hsa05144 | 2.69745388 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.69165836 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.67736183 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.63949475 |
| 10 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.55565964 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.53866991 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.39928976 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.37688255 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 2.34004651 |
| 15 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.32835654 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.29956696 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.27793836 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.24462762 |
| 19 | * Salmonella infection_Homo sapiens_hsa05132 | 2.20030625 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 2.14300905 |
| 21 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 2.10536331 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.05586976 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.03832810 |
| 24 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.87818149 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.87409954 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.85669697 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.76616876 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.73945402 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.73747913 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.72004712 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.58132402 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.57663287 |
| 33 | Prion diseases_Homo sapiens_hsa05020 | 1.42656274 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35002447 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33929205 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.27568553 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26034078 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.24522325 |
| 39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.18279439 |
| 40 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18142144 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.16797838 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.11207579 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 1.10330164 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05863572 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 0.96985725 |
| 46 | Amoebiasis_Homo sapiens_hsa05146 | 0.95873565 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 0.95244190 |
| 48 | Phagosome_Homo sapiens_hsa04145 | 0.90546201 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 0.89641712 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.86372052 |
| 51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81759133 |
| 52 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.80680730 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79780675 |
| 54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.79744782 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77617966 |
| 56 | Bladder cancer_Homo sapiens_hsa05219 | 0.77581904 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67448150 |
| 58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66065645 |
| 59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65277567 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63772042 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62034277 |
| 62 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.57580404 |
| 63 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.53775831 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53048104 |
| 65 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52030798 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49900154 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48746038 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46495241 |
| 69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45616820 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39200305 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.38593372 |
| 72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35955497 |
| 73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35413832 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34760457 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.30417422 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27726844 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.25112464 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.22742079 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.18604547 |
| 80 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.18418428 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.17832356 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.14530121 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.13248640 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.13063387 |
| 85 | Proteasome_Homo sapiens_hsa03050 | 0.12162310 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.12062077 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.11299816 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.10751211 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.08980303 |
| 90 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.06863432 |
| 91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.02912734 |
| 92 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.02778397 |
| 93 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.02390171 |
| 94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.01793134 |
| 95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.01079727 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.00213730 |
| 97 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | -0.0332416 |
| 98 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.0210076 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.0202367 |
| 100 | Notch signaling pathway_Homo sapiens_hsa04330 | -0.0106443 |

